Answers are grounded in this paper and cite their sources.
Cheap-metal-catalyzed asymmetric enyne cycloisomerizations that directly synthesize 1,4-dienes, named here as enyne cyclo-1,4-dienylation (abbreviated as cyclodienylation), remain scarce. The existing methods are largely limited to racemic transformations and mostly for 1,6-enynes. Here, we report a cobalt-catalyzed asymmetric enyne cyclo-1,4-dienylation using both 1,6-enynes and 1,7-enynes, delivering enantioenriched five- and six-membered rings bearing 1,4-diene moieties. The reaction proceeds under mild conditions with an earth-abundant cobalt catalyst and commercially available chiral phosphine ligands, tolerates a broad range of alkyl-, aryl-, and terminal-alkyne substrates as well as carbon-, nitrogen-, and oxygen-tethered enynes, and remains efficient on gram scale with excellent enantioselectivity. Mechanistic experiments and DFT calculations were performed, indicating that the reaction occurs via a pathway involving oxidative cyclometallation, β-H elimination, and reductive elimination. Distortion–interaction analysis was applied to understand the origin of enantioselectivity of the 1,7-enyne cyclodienylation.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: